Predictors and Impact of Myocardial Injury After Transcatheter Aortic Valve Replacement
Why the study?
Cardiac biomarker release post-TAVR is common, but its clinical impact across different valve types and procedural approaches remains unknown.
Population
1,131 consecutive patients undergoing TAVR
Comparison
Degree of cardiac biomarker elevation (CK-MB rise) post-TAVR
Design
Multicenter study
Follow-up
Median of 21 months
Key result
A greater rise in CK-MB levels after transcatheter aortic valve replacement was independently associated with increased 30-day, late overall, and cardiovascular mortality (p < 0.001).
Authors
Loading...
Observational study demonstrates predictors and outcomes of myocardial injury in aortic stenosis patients, indicating opportunities to reduce periprocedural cardiac risk.
Cohort (n=1,131)
Yes
p-value: p=<0.001
Ribeiro et al. (2015) conducted a cohort in Patients undergoing transcatheter aortic valve replacement (TAVR) (n=1,131). Myocardial injury (rise in CK-MB levels) vs. No or lesser rise in CK-MB levels was evaluated on 30-day, late overall and cardiovascular mortality (p=<0.001). A greater rise in CK-MB levels after transcatheter aortic valve replacement was independently associated with increased 30-day, late overall, and cardiovascular mortality (p < 0.001).